LUCD
LUCD
NASDAQ · Health Care

Lucid Diagnostics Inc

$1.22
+0.07 (+6.09%)
As of Feb 8, 2:07 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +2,948.4% upside
Low Target $20.54
Average Target $37.19
High Target $43.70
Current Price $1.22
Current
$1.22
Target
$37.19
$20.54 $37.19 avg $43.70
Scenario Analysis
Bear Case
$20.54
1,583.6%
Low target
Base Case
$37.19
+2,948.4%
Avg target
Bull Case
$43.70
+3,482.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$42.12
-97.1% from high
52-Week Low
$17.65
+-93.1% from low
Target vs 52W High
$37.19
-11.7% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%